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Objective: To determine the prevalence of MRSA infection and its antibiotic susceptibility pattern in patients 
undergoing abdominal and vaginal surgeries.    
Material and Method: A retrospective observational study was conducted at Rawal General & Dental Hospital, 
Islamabad from September 2017 to September 2018 and data of approximately 300 patients were retrieved which 
included culture and sensitivity reports of wound and vaginal swabs of patients undergoing abdominal and 
vaginal surgeries to see prevalence of MRSA and antibiotics to which it is susceptible. Obesity was a risk factor 
and patients with immune-compromised status were not included. 
Result:  Female patients were most affected by 87%. Of the total cases, patients between ages 21 to 30 years were 
more frequent. The rate of MRSA was 37.0% in this study. There were 63% of patients who showed methicillin 
resistance. Linezolid was more effective in MRSA and was sensitive in 81%.  
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Methicillin-resistant staphylococcus aureus is a 
worldwide public health problem, that causes 
significant morbidity and mortality and elevated 
health care costs.1 There were an estimated 94360 
invasive MRSA in the United States in 2005, causing 
18000 deaths per year. Infections caused by MRSA are 
associated with longer hospital stay and financial 
burden on family and society.2 
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The most common cause of hospital-acquired 
infections is MRSA. Staph aureus is the causative 
agent of skin and soft tissue infection which causes 
morbidly and mortality contributing to increased 
health care cost.3 
A study was conducted in Uttar Pradesh in which 549 
strains of staphylococcus aureus were isolated, 301 
were found to be methicillin-resistant.4 Another study 
witnessed that more than 80% of MRSA were found to 
be resistant to penicillin, cotrimoxazole, ciprofloxacin, 
gentamicin, erythromycin, tetracycline, 60.5% to 
amikacin and 47.5% to netilmicin. No strains were 
resistant to vancomycin. 32.0% of MRSA strains were 
found multidrug-resistant.5  
Europe has a strong presence of MRSA accounting for 
44% of nosocomial infections in the year 2008. 
Hospital-acquired MRSA has a high prevalence in 
Australia, North Africa, and the Middle East. This 
study was aimed at determining the intensity of the 
spread of MRSA infection in the local settings and to 




To determine the prevalence of MRSA infection and its 
antibiotic susceptibility pattern in patients undergoing 




This retrospective study was conducted at the 
Obstetrics and Gynaecology Department and the 
Surgical Department of RIHS, Islamabad 
The duration of the study was 1 year from September 
2017 to September 2018. 
The sample size was calculated by the WHO calculator 
by following assumptions; a confidence level of 95.5%, 
and an alpha error of 5% and an anticipated 
population proportion of 26.6%. The study sample size 
was 300 cases. 
Post-operative wound infection in patients who 
underwent abdominal and vaginal surgeries e.g. 
cesarean section, abdominal and vaginal 
hysterectomies, and laparotomies were included in 
this study. The cases having hospital stay < 2 days, 
immuno-compromised and those cases on steroids 
were excluded. 
We collected data of approximately 300 patients in 
whom wound swabs and vaginal swabs were sent to 
the laboratory for culture and sensitivity. MRSA 
strains were identified by standard technique. The 
antibiotic susceptibility pattern of all the MRSA strains 
was to determine against the antibiotics; Penicillin, 
erythromycin, cotrimoxazole, amikacin, 
chloramphenicol, tigecycline, doxycycline, 
clindamycin, ciprofloxacin, vancomycin, and linezolid. 
The postoperative hospital stay was evaluated from a 
historical record. 
Statistical packages for social science were used to 
analyze data. Frequency and percentages were 
computed for categorical variables like gender. Mean 
and the standard deviation was estimated for age, BMI 




There were a total of 300 cases in this study. Females 
were predominant with 263 (87.7%) proportion. 
(Table-1)  
Most of the study patients 96 (32.0%) were between 21 
to 30 years of age. Almost two thirds (58.0%) were in 
children, adolescents and younger ages up to 30 years. 
The rest of the study cases were above 30 years of age. 
(Table-2)  
The rate of MRSA was found out to be 111 (37.0%) in 
this study. (Figure-I)  
Of the MRSA cases, 70 (63.0%) patients showed 
resistance to methicillin. The most sensitive drug was 
Linezolid (81.0%) which was found highly effective in 
MRSA in our local settings.  
 
Table 1: Gender distribution in the study (n=300) 
Gender No of Cases % age  
Male  37 12.3% 
Female  263 87.7% 
 
Table 2: Age of patients in the study (n=300) 
Age Categories No of Cases % age  
Up to 15 Years 42 14% 
16 to 20 Years 36 12% 
21 to 30 Years 96 32% 
31 to 40 Years 42 14% 
41 to 50 Years 36 12% 
51 to 60 Years 42 14% 
61 or above 6 2% 
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Hospital and community‐acquired Staphylococcus 
aureus infections pose a substantial burden in terms of 
morbidity, mortality and healthcare costs. More than 
two-thirds of the current study cases had MRSA who 
underwent various abdominal and vaginal surgeries. 
Similar to previous studies from the national and 
regional settings as well as developed and western 
countries have also witnessed the spread of MRSA in 
their hospital settings as well as community settings. 
An Indian study reported 61% MRSA rate.4 Similarly, 
many western countries have witnessed MRSA in up 
to 44% hospitalized cases.5 This high rate of MRSA is 
alarming and a global threat.  
The introduction of new antibiotics to counter this 
pathogen has frequently been closely followed by the 
emergence of resistant strains. In the current study, 
there were almost two-third cases with resistant 
MRSA to most of the antibacterials. A comparative 
study from…. reported 80% cases with a resistant 
strain of MRSA to common antibacterials like 
penicillins, cotrimoxazole, ciprofloxacin, gentamicin, 
erythromycin, and tetracycline.5 Most significantly, S.  
Aureus isolates, resistant to β‐lactams have become 
common, and many of these are also resistant to β‐
lactamase‐resistant penicillins. The rapid spread of 
methicillin‐resistant S.  Aureus (MRSA) clones across 
the world often result in hospital outbreaks, but the 
implementation of appropriate control measures 
usually reduces prevalence to sporadic levels. 
However, the recent emergence of MRSA infections in 
the community, affecting patients with no established 
risk factors for MRSA acquisition, is likely to impact 
significantly on future strategies for control of 
nosocomial MRSA. In contrast to other antibiotic 
classes, drugs sensitive to S.  Aureus after many years 
of their clinical introduction had still remained the 
mainstay of treatment for MRSA infections. 
With the various study populations and data 
gathering methodologies, comparisons between 
epidemiological reports are difficult to make. 
However, we were not able to identify firm evidence 
that there has been a significant decrease in total or 
healthcare-associated MRSA Infections in our hospital. 
We conclude from our study that the use of proper 
antibiotics that are effective against MRSA could have 
beneficial effects for the individuals and overall 
healthcare settings. Thus, proper prophylactic 
treatment should be used in high-risk populations. 
They can be highly effective in the prevention of 
wound infections with MRSA and further 




MRSA is a common cause of antibiotic resistance in 
patients with wound infection and longer hospital 
stays. Although preoperative measures like anaemia 
correction, proper hygiene maintenance, use of 
appropriate sterile instruments and meticulous 
surgical technique play an important part in the 
prevention of MRSA infection, however, Prophylactic 
treatment with sensitive antibiotics like linezolid and 
chloramphenicol in high-risk populations can prevent 
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